Understanding the molecular mechanisms underlying ccRCC is enhanced by the occurrence of missense mutations and the discovery of commonly mutated genes like VHL and PBRM1.These findings also raise the possibility of developing targeted therapeutic strategies based on specific genetic alterations. The gene discussed is VHL; the disease is nonpapillary renal cell carcinoma.